Immediate Impact
1 by Nobel laureates 62 standout
Citing Papers
Accelerating antiviral drug discovery: lessons from COVID-19
2023 Standout
Advances in covalent drug discovery
2022 Standout
Works of S. Flamm being referenced
Short‐duration treatment for chronic hepatitis C virus with daclatasvir, asunaprevir, beclabuvir and sofosbuvir (FOUR ward study)
2016
104 BOCEPREVIR (B) COMBINATION THERAPY IN NULL RESPONDERS (NR): RESPONSE DEPENDENT ON INTERFERON RESPONSIVENESS
2008
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| S. Flamm | 175 | 161 | 37 | 18 | 179 | |
| H. Fontaine | 268 | 259 | 35 | 22 | 279 | |
| Lynn M. Frazier | 273 | 260 | 59 | 14 | 295 | |
| Ossama Ashraf Ahmed | 170 | 150 | 23 | 25 | 210 | |
| E. Gane | 206 | 194 | 39 | 28 | 222 | |
| Katarzyna Fleischer‐Stępniewska | 276 | 244 | 67 | 13 | 293 | |
| K. Kaita | 157 | 143 | 31 | 14 | 188 | |
| Elizabeth Akoth | 232 | 211 | 40 | 10 | 247 | |
| S. Roberts | 272 | 245 | 69 | 19 | 281 | |
| A. Yosry | 231 | 208 | 20 | 18 | 251 | |
| Theodore Ngatchu | 149 | 174 | 27 | 13 | 206 |
All Works
Loading papers...